Microbial Inoculation Improves Growth, Nutritional and Physiological Aspects of <i>Glycine max</i> (L.) Merr.

Considering a scenario where there is a low availability and increasing costs of fertilizers in the global agricultural market, as well as a finitude of important natural resources, such as phosphorus (P), this study tested the effect of the inoculation of rhizospheric or endophytic microorganisms isolated from <i>Hymenaea courbaril</i> and <i>Butia purpurascens</i> on the growth promotion of <i>Glycine max</i> (L.) Merr. The tests were conducted in a controlled greenhouse system, and the effects of biofertilization were evaluated using the following parameters: dry biomass, nutritional content, and photochemical and photosynthetic performance of plants. Seed biopriming was performed with four bacterial and four fungal isolates, and the results were compared to those of seeds treated with the commercial product Biomaphos^®. Overall, microbial inoculation had a positive effect on biomass accumulation in <i>G. max</i>, especially in strains PA12 (<i>Paenibacillus alvei</i>), SC5 (<i>Bacillus cereus</i>), and SC15 (<i>Penicillium sheari</i>). The non-inoculated control plants accumulated less nutrients, both in the whole plant and aerial part, and had reduced chlorophyll index and low photosynthetic rate (<i>A</i>) and photochemical efficiency. Strains PA12 (<i>P. alvei</i>), SC5 (<i>B. cereus</i>), and 328EF (<i>Codinaeopsis</i> sp.) stood out in the optimization of nutrient concentration, transpiration rate, and stomatal conductance. Plants inoculated with the bacterial strains PA12 (<i>P. alvei</i>) and SC5 (<i>B. cereus</i>) and with the fungal strains 328EF (<i>Codinaeopsis</i> sp.) and SC15 (<i>P. sheari</i>) showed the closest pattern to that observed in plants treated with Biomaphos^®, with the same trend of direction of the means associated with chlorophyll index, (<i>A</i>), dry mass, and concentration of important nutrients such as N, P, and Mg. We recommend the use of these isolates in field tests to validate these strains for the production of biological inoculants as part of the portfolio of bioinputs available for <i>G. max</i>.